


Neuralia TMS Revenue
Mental Health Care • Perth, Western Australia, Australia • 1-10 Employees
Neuralia TMS revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Mental Health Care industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Key Contact at Neuralia TMS
Riti Chetty
Managing Director
Company overview
| Headquarters | 7/25 Foss St, Palmyra, Western Australia 6157, AU |
| Website | |
| NAICS | 621112 |
| Keywords | Addiction, Depression, Neurological Disorders, Chronic Pain, Insomnia, Ptsd, Cognitive Enhancement, Bipolar Disorder, Anxiety Disorder |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
About Neuralia TMS
Neuralia TMS specializes in the administration of Transcranial Magnetic Stimulation (TMS) treatments for a range of conditions, including Depression, PTSD, OCD, Chronic Pain (including Fibromyalgia), and more, in the Perth area. Our services offer numerous advantages for patients seeking effective treatment: Medicare Coverage: 🏥 Our TMS treatments are covered by Medicare, ensuring accessibility for a wider range of individuals. 💊 Drug-Free Approach: We prioritize non-pharmacological interventions, offering a drug-free alternative to traditional treatment methods. 🔬 Evidence-Based Practice: Our treatment approach is rooted in extensive research spanning over 35 years, ensuring the effectiveness and reliability of TMS therapy. 🧘♂️ Non-Invasive Procedure: TMS is a non-invasive treatment, minimizing risks and eliminating the need for surgical interventions. TMS represents a groundbreaking treatment modality that precisely targets specific brain regions, resulting in long-lasting therapeutic outcomes. By stimulating neural activity in underactive brain areas associated with mental illnesses and chronic pain, TMS fosters lasting changes in brain circuitry. Patients can expect the following advantages when choosing TMS therapy: 💰 Convenience: TMS treatments are designed to seamlessly integrate into patients' daily routines without requiring recovery time or hospital admissions. 🩹 Minimal Disruption: TMS therapy does not induce withdrawal symptoms or downtime, enabling individuals to continue with their regular activities. ⏳ Lasting Effects: The effects of TMS therapy are typically enduring, providing patients with sustained relief from their symptoms. At Neuralia TMS, we are committed to delivering professional, evidence-based, and patient-centered care. Our dedicated team of experts is eager to provide you with transfor
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Neuralia TMS has 3 employees across 2 departments.
Departments
Number of employees
Funding Data
Neuralia TMS has never raised funding before.
Neuralia TMS Tech Stack
Discover the technologies and tools that power Neuralia TMS's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Form builders
WordPress plugins
Maps
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Programming languages
Appointment scheduling
Blogs
Web frameworks
Frequently asked questions
4.8
40,000 users



